Latest Shareholder Approvals News

Eastern Resources Limited reports solid progress in its lithium and iron projects during the December 2024 quarter, highlighted by promising metallurgical test results from Lepidolite Hill.

Leeuwin Metals Limited (ASX:LM1) has secured a transformative acquisition of the Marda Gold Project, significantly enhancing its portfolio with a high-grade gold asset in Western Australia. The company also announced a $3.25 million capital raising to fund extensive exploration across its Australian and Canadian projects.

Leeuwin Metals has secured A$3.25 million through a two-tranche placement, positioning the company to complete its transformative Marda Gold Project acquisition and ramp up exploration across Australia and Canada in 2025.

Leeuwin Metals has inked a binding deal to acquire the Marda Gold Project from Ramelius Resources, marking a strategic expansion into Western Australia's prolific goldfields. Alongside promising iron ore results from its West Pilbara project, Leeuwin is positioning itself as a diversified explorer with significant growth potential.

Myer Holdings has completed its strategic acquisition of Just Group, adding five key apparel brands to its portfolio and issuing 890.5 million new shares to Premier Investments.

Galan Lithium has received US$3 million from Latam Resources, an affiliate of Chemphys, to fund ongoing operations at its Hombre Muerto West project, advancing its path toward production and an offtake prepayment facility expected in Q1 2025.

Great Southern Mining has launched a fresh drilling campaign at its 100% owned Duketon Gold Project, targeting the promising Golden Boulder prospect with the aim to build on prior high-grade results.

DomaCom Limited reported a steep $4.5 million loss for the half-year ending December 2023, driven by declining revenues and operational hurdles, including a temporary suspension of its fund's Product Disclosure Statement. The company is actively pursuing capital raises to stabilize its position.

A1 Investments & Resources Ltd reported minimal cash flow activity for the December 2023 quarter while actively pursuing renewable energy acquisition opportunities in Japan and Australia.

InhaleRx has corrected its quarterly report and revealed a $38.5 million funding deal to fast-track clinical trials for its inhaled therapies targeting breakthrough cancer pain and panic disorder, aiming for FDA approval.

Bod Science Limited reports a modest net cash inflow of $51,000 for Q2 FY2025, supported by increased customer receipts and intellectual property sales, while navigating a complex Deed of Company Arrangement and pending acquisition.

Native Mineral Resources secures a conditional $6.5 million investment from entrepreneur Wes Maas, supporting its Queensland gold projects and targeting production restart in Q3 2025.